Contact
Please use this form to send email to PR contact of this press release:
AffaMed Therapeutics 宣布与EverInsight Therapeutics达成最终合并协议并任命赵大尧博士为CEO
TO:
Edmond Lococo
ICR Asia
+86 138 1079 1408